ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

121
Analysis
Health Care • Japan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
Refresh
•11 Jun 2020 12:22

🇯🇵 JAPAN - Stress Tests Part 1 - Altman Z-Scores

STRESS TESTS - This Insight is the first in a series that will use a variety of standard and less-frequently used 'stress-tests' to look through...

Logo
606 Views
Share
bullish•Takeda Pharmaceutical
•29 Apr 2020 14:02

Takeda Pharma Divests Yet Another Non-Core Asset to Pay-Off Debt and Focus on Core Areas

On 24th April, Takeda Pharmaceutical announced that it has entered into an agreement to sell off a portfolio of select non-core over the counter...

Share
bullish•Quantitative Analysis
•28 Apr 2020 16:36

More Covering on Consumer Staples and Discretionary

The short notional in the market for the data released 28 April is US$33.44bn (down by US$62mm excluding FX movements and ETFs) with the largest...

Logo
296 Views
Share
bullish•Johnson & Johnson
•02 Apr 2020 18:57

J&J’s Purchase of Takeda’s Surgical Patch Subject to EU Investigation; Expect a Deal Anyways

In May 2019, Japan’s biggest drugmaker, Takeda announced the sale of its surgical patch product, TachoSil to Johnson & Johnson’s subsidiary...

Share
bullish•Astellas Pharma
•30 Dec 2019 14:01

Japan’s Astellas Pharma Buys US-Based Xyphos Biosciences Inc.

It was reported by Reuters and several other media that the Japan-based Astellas Pharma has bought the US-based Xyphos Bioscience Inc. in a deal...

Share
x